These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9453101

  • 1. Gaucher disease: assessment of skeletal involvement and therapeutic responses to enzyme replacement.
    Hermann G, Pastores GM, Abdelwahab IF, Lorberboym AM.
    Skeletal Radiol; 1997 Dec; 26(12):687-96. PubMed ID: 9453101
    [Abstract] [Full Text] [Related]

  • 2. Use of various diagnostic methods in a patient with Gaucher disease type I.
    Farahati J, Trenn G, John-Mikolajewski V, Zander C, Pastores GM, Sciuk J, Reiners C.
    Clin Nucl Med; 1996 Aug; 21(8):619-25. PubMed ID: 8853914
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K, Moos L, Mengel E, Lollert A, Hoffmann C, Brixius-Huth M, Wagner D, Düber C, Staatz G.
    Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
    [Abstract] [Full Text] [Related]

  • 8. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
    Rosenthal DI, Doppelt SH, Mankin HJ, Dambrosia JM, Xavier RJ, McKusick KA, Rosen BR, Baker J, Niklason LT, Hill SC.
    Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regression of skeletal changes in type 1 Gaucher disease with enzyme replacement therapy.
    Pastores GM, Hermann G, Norton KI, Lorberboym M, Desnick RJ.
    Skeletal Radiol; 1996 Jul; 25(5):485-8. PubMed ID: 8837283
    [Abstract] [Full Text] [Related]

  • 11. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
    Poll LW, vom Dahl S, Koch JA, Börner D, Willers R, Cohnen M, Jung G, Scherer A, Niederau C, Häussinger D, Mödder U.
    Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Scintigraphic monitoring of reticuloendothelial system in patients with type 1 Gaucher disease on enzyme replacement therapy.
    Lorberboym M, Pastores GM, Kim CK, Hermann G, Glajchen N, Machac J.
    J Nucl Med; 1997 Jun; 38(6):890-5. PubMed ID: 9189137
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
    El-Beshlawy A, Ragab L, Youssry I, Yakout K, El-Kiki H, Eid K, Mansour IM, Abd El-Hamid S, Yang M, Mistry PK.
    J Inherit Metab Dis; 2006 Feb; 29(1):92-8. PubMed ID: 16601874
    [Abstract] [Full Text] [Related]

  • 16. Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher.
    vom Dahl S, Poll LW, Häussinger D.
    Br J Haematol; 2001 Jun; 113(4):1084-7. PubMed ID: 11442513
    [No Abstract] [Full Text] [Related]

  • 17. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J, Szücs FZ, Benkö K, Maródi L.
    Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Gaucher's disease: diagnosis and therapy].
    Petrides PE.
    Dtsch Med Wochenschr; 1995 Aug 25; 120(34-35):1177-82. PubMed ID: 7656853
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.